Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
Medistim ASA
MD1Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which is designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation of fragile or calcified vessels; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway. Address: Oekernveien 94, Oslo, Norway, 0579
Analytics
Precio Objetivo de WallStreet
2 102.02 NOKRelación P/E
28.5586Rentabilidad por dividendo
2.83 %Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave MD1
Análisis de dividendos MD1
Aumento del dividendo durante 5 años
125 %Crecimiento continuo
9 añosRatio de pago medio en 5 años
105 %Tendencia del payout MD1
Valoración de la acción MD1
Finanzas MD1
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |